CHEOY:OTCMKTS
Cochlear Ord ADR
US$ 33.84
arrow_downward
-7.14%(-2.60) Siku 1
23 Apr, 16:00:00 GMT -4 · USD
search
Alama zote
Siku 1
Siku 5
Mwezi 1
Miezi 6
YTD
Mwaka 1
Miaka 5
ISIZIDI
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya CHEOY...
Fungua
US$ 35.25
Juu
US$ 35.25
Chini
US$ 33.56
Mtaji wa soko
6.42B
Wastani wa kiasi cha mauzo
elfu 57.92
Kiasi cha mauzo ya hisa
elfu 114.60
Juu kwa wiki 52
US$ 105.60
Chini kwa wiki 52
US$ 33.56
Beta
1.10
Hisa za wawekezaji
130.80M
Idadi ya wafanyakazi
elfu 6
Habari
Kutoka kwenye vyanzo vya wavuti
The Motley Fool Australia
·
saa 1 iliyopita
How high could Cochlear shares bounce back? Brokers disagree
MSN
·
saa 1 iliyopita
3 ASX 200 shares too cheap to ignore after sell-offs
BioWorld News
·
saa 10 zilizopita
Cochlear’s 39% stock plunge resets ‘defensive growth’ narrative
Kalkine Media
·
saa 16 zilizopita
What Triggered the Sharp Fall in Cochlear Shares?
Wasifu
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Kuhusu Cochlear Ord ADR
Afisa Mkuu Mtendaji (CEO)Dig Howitt
Wafanyakazielfu 5.5
Lilianzishwa1981
Makao makuuSydney, New South Wales, Australia
Sekta-
Tovuticochlear.com
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi